ResearcherUniversity of CincinnatiActive in the last 2 years
Syed A. Ahmad
Matched on OpenAlex author ID A5128199099. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 27
2026: 4 papers
Papers 4
- Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis. Co-author DOI 10.1093/jnci/djag235↗
- Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-026-19990-7↗
- ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-026-20039-y↗
- ASO Author Reflections: Looking Beyond Imaging-Multimodal Response Assessment after Modern Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. First author DOI 10.1245/s10434-026-20107-3↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paul H. McClelland · 3 shared papers, 2026 · strength 1.16
- Paper ASO Author Reflections: Looking Beyond Imaging-Multimodal Response Assessment after Modern Neoadjuvant Therapy for Panc… DOI 10.1245/s10434-026-20107-3↗
- Paper Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-19990-7↗
- Paper ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Ad… DOI 10.1245/s10434-026-20039-y↗
- Gregory C. Wilson · 3 shared papers, 2026 · strength 0.71
- Paper Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-19990-7↗
- Paper ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Ad… DOI 10.1245/s10434-026-20039-y↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Sameer H. Patel · 3 shared papers, 2026 · strength 0.71
- Paper Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-19990-7↗
- Paper ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Ad… DOI 10.1245/s10434-026-20039-y↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Davendra P. S. Sohal · 2 shared papers, 2026 · strength 0.53
- Paper Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-19990-7↗
- Paper ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Ad… DOI 10.1245/s10434-026-20039-y↗
- Ryan P. Johnson · 2 shared papers, 2026 · strength 0.53
- Paper Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-19990-7↗
- Paper ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Ad… DOI 10.1245/s10434-026-20039-y↗
- Jordan R. Kharofa · 2 shared papers, 2026 · strength 0.53
- Paper Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-19990-7↗
- Paper ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Ad… DOI 10.1245/s10434-026-20039-y↗
- Olugbenga Olanrele Olowokure · 2 shared papers, 2026 · strength 0.53
- Paper Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-19990-7↗
- Paper ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Ad… DOI 10.1245/s10434-026-20039-y↗
- Giuseppe Malleo · 1 shared paper, 2026 · strength 0.19
- Ryan K. Schmocker · 1 shared paper, 2026 · strength 0.19
- Jin Peng He · 1 shared paper, 2026 · strength 0.19
- Russell F. Palm · 1 shared paper, 2026 · strength 0.19
- José Oberholzer · 1 shared paper, 2026 · strength 0.19
- Ning Pu · 1 shared paper, 2026 · strength 0.19
- Liang Liu · 1 shared paper, 2026 · strength 0.19
- Patricia Sánchez‐Velázquez · 1 shared paper, 2026 · strength 0.19
- Dilmurodjon Eshmuminov · 1 shared paper, 2026 · strength 0.19
- Víctor López‐López · 1 shared paper, 2026 · strength 0.19
- Michael C. Frey · 1 shared paper, 2026 · strength 0.19
- Benedetto Ielpo · 1 shared paper, 2026 · strength 0.19
- Elena B. Rangelova · 1 shared paper, 2026 · strength 0.19
- So Heun Lee · 1 shared paper, 2026 · strength 0.19
- Gabriella Lionetto Lionetto · 1 shared paper, 2026 · strength 0.19
- Sarah E. Hoffe · 1 shared paper, 2026 · strength 0.19
- Timothy Michael Pawlik · 1 shared paper, 2026 · strength 0.19
- Ralph Fritsch · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.